Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis
Cardiac dysfunction is a common complication of sepsis in individuals with preexisting coronary disease and portends a poor prognosis when progressing to ischemic cardiogenic shock. In this setting, maximal medical therapy in isolation is often inadequate to maintain cardiac output for patients who...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2017/8407530 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556057583419392 |
|---|---|
| author | Praveen George Mukta C. Srivastava Jonathan Ludmir Robert M. Reed Semhar Z. Tewelde Anuj Gupta Michael T. McCurdy |
| author_facet | Praveen George Mukta C. Srivastava Jonathan Ludmir Robert M. Reed Semhar Z. Tewelde Anuj Gupta Michael T. McCurdy |
| author_sort | Praveen George |
| collection | DOAJ |
| description | Cardiac dysfunction is a common complication of sepsis in individuals with preexisting coronary disease and portends a poor prognosis when progressing to ischemic cardiogenic shock. In this setting, maximal medical therapy in isolation is often inadequate to maintain cardiac output for patients who are poor candidates for immediate revascularization. Furthermore, the use of vasopressors and inotropes increases myocardial demand and may lead to further injury. Percutaneous ventricular assist devices provide a viable option for management of severe shock with multiorgan failure. The Impella is one of several novel mechanical support systems that can effectively augment cardiac output while reducing myocardial demand and serve as a bridge to recovery from severe hemodynamic compromise. This case report describes the successful utilization of the Impella 2.5 in a patient with baseline profound anemia and coronary artery disease (CAD) presenting in combined distributive and cardiogenic shock associated with a type 2 myocardial infarction complicating sepsis. |
| format | Article |
| id | doaj-art-395553f91cec4e88b3d160f429383b25 |
| institution | Kabale University |
| issn | 2090-6404 2090-6412 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Cardiology |
| spelling | doaj-art-395553f91cec4e88b3d160f429383b252025-02-03T05:46:23ZengWileyCase Reports in Cardiology2090-64042090-64122017-01-01201710.1155/2017/84075308407530Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating SepsisPraveen George0Mukta C. Srivastava1Jonathan Ludmir2Robert M. Reed3Semhar Z. Tewelde4Anuj Gupta5Michael T. McCurdy6Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD, USADivision of Cardiology, University of Maryland School of Medicine, Baltimore, MD, USADivision of Cardiology, University of Maryland School of Medicine, Baltimore, MD, USADivision of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USADivision of Cardiology, University of Maryland School of Medicine, Baltimore, MD, USADivision of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USACardiac dysfunction is a common complication of sepsis in individuals with preexisting coronary disease and portends a poor prognosis when progressing to ischemic cardiogenic shock. In this setting, maximal medical therapy in isolation is often inadequate to maintain cardiac output for patients who are poor candidates for immediate revascularization. Furthermore, the use of vasopressors and inotropes increases myocardial demand and may lead to further injury. Percutaneous ventricular assist devices provide a viable option for management of severe shock with multiorgan failure. The Impella is one of several novel mechanical support systems that can effectively augment cardiac output while reducing myocardial demand and serve as a bridge to recovery from severe hemodynamic compromise. This case report describes the successful utilization of the Impella 2.5 in a patient with baseline profound anemia and coronary artery disease (CAD) presenting in combined distributive and cardiogenic shock associated with a type 2 myocardial infarction complicating sepsis.http://dx.doi.org/10.1155/2017/8407530 |
| spellingShingle | Praveen George Mukta C. Srivastava Jonathan Ludmir Robert M. Reed Semhar Z. Tewelde Anuj Gupta Michael T. McCurdy Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis Case Reports in Cardiology |
| title | Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis |
| title_full | Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis |
| title_fullStr | Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis |
| title_full_unstemmed | Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis |
| title_short | Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis |
| title_sort | augmenting function for infarction from infection impella 2 5 for ischemic cardiogenic shock complicating sepsis |
| url | http://dx.doi.org/10.1155/2017/8407530 |
| work_keys_str_mv | AT praveengeorge augmentingfunctionforinfarctionfrominfectionimpella25forischemiccardiogenicshockcomplicatingsepsis AT muktacsrivastava augmentingfunctionforinfarctionfrominfectionimpella25forischemiccardiogenicshockcomplicatingsepsis AT jonathanludmir augmentingfunctionforinfarctionfrominfectionimpella25forischemiccardiogenicshockcomplicatingsepsis AT robertmreed augmentingfunctionforinfarctionfrominfectionimpella25forischemiccardiogenicshockcomplicatingsepsis AT semharztewelde augmentingfunctionforinfarctionfrominfectionimpella25forischemiccardiogenicshockcomplicatingsepsis AT anujgupta augmentingfunctionforinfarctionfrominfectionimpella25forischemiccardiogenicshockcomplicatingsepsis AT michaeltmccurdy augmentingfunctionforinfarctionfrominfectionimpella25forischemiccardiogenicshockcomplicatingsepsis |